Analytical Data
-
Gene name
ARAC
- Application
-
Alternative Names
ARAC；Deoxycytidine kinase
-
Species
E.coli
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P0A9E0
-
Expression Region
1-292aa
-
AA Sequence
MAEAQNDPLLPGYSFNAHLVAGLTPIEANGYLDFFIDRPLGMKGYILNLTIRGQGVVKNQGREFVCRPGDILLFPPGEIHHYGRHPEAREWYHQWVYFRPRAYWHEWLNWPSIFANTGFFRPDEAHQPHFSDLFGQIINAGQGEGRYSELLAINLLEQLLLRRMEAINESLHPPMDNRVREACQYISDHLADSNFDIASVAQHVCLSPSRLSHLFRQQLGISVLSWREDQRISQAKLLLSTTRMPIATVGRNVGFDDQLYFSRVFKKCTGASPSEFRAGCEEKVNDVAVKLS
-
Molecular Weight
33.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ARAC (Autoantigen Reactive in Antibody-Capture) is a recombinant protein that has garnered significant attention in recent years due to its potential role in autoimmunity and cancer research. Autoantibodies are often produced in response to altered protein expressions, and ARAC has been identified as a key autoantigen in various autoimmune diseases. The study of ARAC involves understanding its structure, function, and the mechanisms by which it elicits an immune response. Researchers are particularly interested in ARAC for its implications in diagnostic and therapeutic applications. By elucidating the pathways involved in ARAC-related autoantibody production, scientists hope to develop more effective biomarkers for early detection of autoimmune conditions and novel strategies for targeted therapy. Additionally, ARAC's involvement in tumor-associated immune responses makes it a candidate for cancer immunotherapy, which aims to harness the body’s immune system to combat tumors. The complexities of ARAC's interactions with immune cells, as well as its expression profiles in different pathological states, continue to be areas of active investigation, offering a promising frontier for both fundamental research and clinical applications.
